Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer
Lua Eiriksson(Juravinski Hospital), Sarah E. Ferguson(University Health Network), Steven Gallinger(University Health Network), Helen Mackay(Sunnybrook Health Science Centre), Blaise Clarke(Princess Margaret Cancer Centre), Aaron Pollett(Mount Sinai Hospital), Amit M. Oza(Ontario Institute for Cancer Research), Melyssa Aronson, Golnessa Mojtahedi(University Health Network), Christine Massey(University of Vermont), Marcus Q. Bernardini(University Health Network)
Cited by 9
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
|The Lancet|2014|1.8k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k